Dean Investment Associates’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Dean Investment Associates’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-19,389	Closed	-$1.99M	–	235
2021 Q4	$1.99M	Sell	19,389 -1,257	-6%	-$121K	0.35%	108
2021 Q3	$1.81M	Sell	20,646 -609	-3%	-$55.1K	0.34%	116
2021 Q2	$1.9M	Buy	21,255 +479	+2%	+$40.5K	0.35%	117
2021 Q1	$1.58M	Buy	+20,776	New	+$1.57M	0.3%	146

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dean Investment Associates's SYNH Position: Q1 2022 in Review

Dean Investment Associates sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 19,389 shares — an estimated $1.99M sold.

Dean Investment Associates first reported a position in SYNH in Q1 2021 and held it in 4 quarters. The position peaked at $1.99M in Q4 2021. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

Dean Investment Associates reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Dean Investment Associates sold 19,389 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.99M.
Dean Investment Associates first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 4 quarters.
Dean Investment Associates's Syneos Health, Inc. Class A Common Stock position peaked at $1.99M in Q4 2021.
366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Dean Investment Associates's 13F filing for Q1 2022, filed 11 May 2022.